Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy

International Journal of Cardiology

Volumn 74, Issue 1, 2000, Pages 67-74

  Boffa, G M ^a   Zanco, P ^b   Della Valentina, P ^a   Cardaioli, P ^a   Thiene, G ^a   Chioin, R ^a   Dalla Volta, S ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Nuclear Medicine PET Center   (Italy)

Author keywords

Dilated cardiomyopathy; Ischemic cardiomyopathy; Positron emission tomography

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE F 18; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEART DILATATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AMMONIA; CARDIOMYOPATHY, DILATED; CORONARY CIRCULATION; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NITROGEN ISOTOPES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034640914     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00245-X     Document Type: Article

References (28)

1. Giseboyd JD, Bennett LE, Keck BM et al. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth official report - 1998. J Heart Lung Transplant 1998;17:656-68.
2. Burch GE, Giles TD, Colcolough HL. Ischemic cardiomyopathy. Am Heart J 1970;79:291-2.
3. Gersh BI, Braunwald E, Rutherford JD. Chronic coronary artery disease. In: Bruanwald E, editor, Heart Disease. A Textbook of Cardiovascular Medicine, Philadelphia: W.B. Saunders, 1997, pp. 1289-365.
4. Williams JF, Bristow MR, Fowler MB et al. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on evaluation and management of heart failure). Circulation 1995;92:2764-98.
5. Diaz RA, Nihoyannopoulos P et al. Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary induced congestive heart failure. Am J Cardiol 1991;68:1224-7.
6. Sawada SG, Ryan T, Segar D et al. Distinguishing ischemic cardiomyopathy from nonischemic dilated cardiomyopathy with coronary echocardiography. J Am Coll Cardiol 1992;19:1233-8.
7. Sharp SM, Sawada SG, Segar DS et al. Dobutamine stress echocardiography: Detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 1994;24:934-9.
8. Vigna C, Russo A, De Rita V et al. Regional wall motion analysis by dobutamine stress echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy. Am Heart J 1996;131:537-43.
9. Iskandrian AD, Hakki AH, Kane S. Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: Differences between patients with primary cardiomyopathy, chronic coronary artery disease or acute myocardial infarction. Am Heart J 1986;111:760-7.
10. Eichhorn EJ, Kosinski EJ, Lewis SM et al. Usefulness of dipyridamole-thallium-201 perfusion scanning for distinguishing ischemic from non-ischemic cardiomyopathy. Am J Cardiol 1988;62:945-51.
11. Chikamori T, Doi YL, Yonezawa Y et al. Value of dipyridamole thallium-201 imaging in non-invasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol 1993;71:674-80.
12. Tauberg SG, Orie JE, Bartlett BE et al. Usefulness of thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy. Am J Cardiol 1993;71:674-80.
13. Budoff MJ, Shavelle DM, Lamont DH et al. Usefulness of electron beam tomography scanning for distinguishing ischemic from non-ischemic cardiomyopathy. J Am Coll Cardiol 1998;32:1173-8.
14. Danias PG, Ahlberg H., Clark BA et al. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 1998;82:1253-8.
15. Ritchie JL, Cheitlin MD, Garson A et al. Guidelines for clinical use of cardiac radionuclide imaging. A report of the American Heart Association/American College of Cardiology Task Force on assessment of diagnostic and therapeutic cardiovascular procedures, committee on radionuclide imaging, developed in collaboration with the American Society of Nuclear Cardiology. Circulation 1995;91:1228-303.
16. Berry JJ, Hoffman JM, Steenbergen C et al. Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. J Nucl Med 1993;34:39-47.
17. Schwaiger M, Beanlands R, Van Dahl J. Metabolic tissue characterization in the failing heart by positron emission tomography. Eur Heart J 1994;15(Suppl D):14-9.
18. Eisenberg JD, Sobel BE, Geltman EM. Differentiation of ischemic from non-ischemic cardiomyopathy with positron emission tomography. Am J Cardiol 1987;59:1410-4.
19. Mody FV, Brunken RC, Stevenson LW et al. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol 1991;17:373-83.
20. Richardson B, McKenna WJ, Bristow M et al. Report of the WHO/IECF task force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-2.
21. Zanco P, Chierichetti F, Fini A et al. Myocardial perfusion, glucose utilization and oxidative metabolism in a patient with left bundle branch block, prior myocardial infarction and diabetes. J Nucl Med 1998;39:261-3.
22. Altehoefer C. LBBB: Challenging our concept of metabolic heart imaging with fluorine-18-FDG and PET? J Nucl Med 1998;39:263-5.
23. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-20.
24. Tillisch J, Brunken R, Marshall R et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
25. Tamaki N, Yonekura Y, Yamashita D et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-5.
26. Nienaberg CA, Brunken RC, Sherman CT et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18:966-78.
27. Eitzman D, Al-Aouar Z, Kanter HL et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
28. Pagano D, Townend J, Littler WA et al. Coronary artery bypass surgery as treatment for ischemic heart failure: The predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998;115:791-9.